Nayzilam

Product manufactured by Ucb, Inc.

Application Nr Approved Date Route Status External Links
NDA211321 None Nasal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Nayzilam Is Indicated For The Acute Treatment Of Intermittent, Stereotypic Episodes Of Frequent Seizure Activity (I.e., Seizure Clusters, Acute Repetitive Seizures) That Are Distinct From A Patient's Usual Seizure Pattern In Patients With Epilepsy 12 Years Of Age And Older. Nayzilam Is A Benzodiazepine Indicated For The Acute Treatment Of Intermittent, Stereotypic Episodes Of Frequent Seizure Activity (I.e., Seizure Clusters, Acute Repetitive Seizures) That Are Distinct From A Patient's Usual Seizure Pattern In Patients With Epilepsy 12 Years Of Age And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Midazolam MIDAZOLAM ZINC95626706

Comments